Home › Funds › Farallon Capital Management › LQDA
Farallon Capital Management position in LQDA
LIQUIDIA CORPORATION · Health Care
Latest position (Q2 2026)8.37M sh
Reported value held$666.94M
Portfolio Weight3.10%
First reportedQ1 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.06M | $30.31M | New |
| Q2 2024 | 2.06M | $24.66M | Hold |
| Q3 2024 | 3.29M | $32.91M | Add |
| Q4 2024 | 3.29M | $38.70M | Hold |
| Q1 2025 | 3.99M | $58.87M | Add |
| Q2 2025 | 4.24M | $52.81M | Add |
| Q3 2025 | 8.57M | $194.78M | Add |
| Q4 2025 | 8.66M | $298.55M | Add |
| Q1 2026 | 8.66M | $326.68M | Hold |
| Q2 2026 | 8.37M | $666.94M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LQDA
- BlackRock Inc 10.79M sh · $860.17M · Q2 2026
- Geode Capital Management 2.12M sh · $169.16M · Q2 2026
- Bank of America Corp 1.99M sh · $158.79M · Q2 2026
- Citadel Advisors 1.95M sh · $155.13M · Q2 2026
- Vanguard Group 4.01M sh · $138.44M · Q4 2025
- D. E. Shaw & Co 1.36M sh · $108.29M · Q2 2026
- Goldman Sachs Group 958.89K sh · $76.45M · Q2 2026
- Northern Trust Corp 709.06K sh · $56.53M · Q2 2026
- Charles Schwab Investment Management 674.03K sh · $53.74M · Q2 2026
- Morgan Stanley 658.44K sh · $52.50M · Q2 2026
- UBS Group AG 606.56K sh · $48.36M · Q2 2026